ERBB2 and breast cancer: The standard of care for BC patients includes surgical resection, chemotherapy, and/or ionizing radiation therapy, with a suite of hormone therapies and other targeted therapies used on a subtype-dependent basis; indeed, these therapies are utilized more commonly in luminal and HER2+ tumors, respectively (1, 11).